GlassScriptPhysician profile
Susan You
NPI 1588226179
$5,031.23
in general payments reported to CMS, 2019-2025
26 companies · $16.62 in 2025
The $16.62 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,289 · 2022: $1,144 · 2023: $1,308 · 2024: $274 · 2025: $16.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $1,232.21 | 2021-2023 | Nalu Neurostimulation System |
| Nevro Corp. | $726.26 | 2021-2023 | Senza |
| Abbvie INC. | $421.23 | 2023-2025 | |
| Boston Scientific Corporation | $266.98 | 2021 | |
| Medtronic, INC. | $240.65 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $197.35 | 2021-2023 | Xtampza, Belbuca |
| Zoll Respicardia, INC. | $196.13 | 2021-2023 | Remede System |
| Biohaven Pharmaceuticals, INC. | $191.14 | 2021 | |
| Electronic Waveform Lab, INC. | $160.39 | 2021-2022 | |
| Abbott Laboratories | $157.11 | 2022 | |
| Redhill Biopharma INC. | $143.54 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.00 | 2023 | |
| Alkermes, INC. | $119.32 | 2023 | Lybalvi |
| Relievant Medsystems, INC. | $112.67 | 2021 | |
| Vertos Medical, INC. | $110.31 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $105.79 | 2023 | Rexulti |
| Almatica Pharma LLC | $100.04 | 2021 | |
| Axonics, INC. | $99.87 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.93 | 2021-2022 | |
| Spr Therapeutics, INC | $87.01 | 2021 | |
| Horizon Therapeutics Plc | $70.43 | 2021-2022 | |
| Impactortho, INC. | $18.31 | 2023 | |
| Otto Bock Healthcare LP | $17.38 | 2021 | |
| Virtus Pharmaceuticals LLC | $16.91 | 2021 | |
| Lilly USA, LLC | $15.89 | 2021 | |
| Biodelivery Sciences International, INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan You listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.